Company news

Healtheuniverse Inc (OTC:HLUN) news

Healtheuniverse Inc news releases on 6ix. Latest, Jun 21, 2025: New data from phase III trial confirms efficacy of Vyepti® (eptinezumab) in Asian population…

View Healtheuniverse Inc →

Press releases & updates

New data from phase III trial confirms efficacy of Vyepti® (eptinezumab) in Asian population with chronic migraine

June 21, 2025

SEC Order Of Suspension Of Trading

March 7, 2007